SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark A. Stang who wrote (7204)4/17/1998 10:40:00 AM
From: RT  Read Replies (1) of 23519
 
Mark,

Glad to see your back. One quick post before I go.
I think it's great news that Viagara sales are soaring. This means that the ED market may be bigger than expected. The faster the ED patients enter the market the greater the spill over to Muse.

To bad those nitwits managing Vivus couldn't have capitalized on Muse the way Pfizer has Viagara. Leland is constantly behind the power curve in everything he does.
It's always, too little too late. With the FDA inspection now completed and production ramping up, we will see what LELAND the incomp can do.

RT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News